US 11090290
Clonidine and/or clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy
granted A61KA61K2300/00A61K31/4168
Quick answer
US patent 11090290 (Clonidine and/or clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy) held by Monopar Therapeutics Inc. expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Monopar Therapeutics Inc.
- Grant date
- Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2300/00, A61K31/4168, A61K45/06, A61K9/006